Zobrazeno 1 - 10
of 71
pro vyhledávání: '"Wing‐Lok Chan"'
Publikováno v:
Life, Vol 14, Iss 8, p 1044 (2024)
In the original publication (doi: 10 [...]
Externí odkaz:
https://doaj.org/article/e5f760e46110471dacd5dcc9430177f7
Autor:
Ka‐Chun Mok, Ho Tsoi, Ellen PS Man, Man‐Hong Leung, Ka Man Chau, Lai‐San Wong, Wing‐Lok Chan, Sum‐Yin Chan, Mai‐Yee Luk, Jessie Y.W. Chan, Jackie K.M. Leung, Yolanda H.Y. Chan, Sellma Batalha, Virginia Lau, David C.W. Siu, Terence K.W. Lee, Chun Gong, Ui‐Soon Khoo
Publikováno v:
Clinical and Translational Medicine, Vol 11, Iss 11, Pp n/a-n/a (2021)
Abstract Hyperpolarization‐activated cyclic nucleotide‐gated (HCN) channels are members of the voltage‐gated cation channel family known to be expressed in the heart and central nervous system. Ivabradine, a small molecule HCN channel‐blocker
Externí odkaz:
https://doaj.org/article/89dc802a66c04d34bba35fe0b981b854
Autor:
Ho Tsoi, Ellen PS Man, Man‐Hong Leung, Ka‐Chun Mok, Ka‐Man Chau, Lai‐San Wong, Wing‐Lok Chan, Sum‐Yin Chan, Mai‐Yee Luk, Cheuk‐Nam Cheng, Ui‐Soon Khoo
Publikováno v:
Clinical and Translational Medicine, Vol 11, Iss 10, Pp n/a-n/a (2021)
Externí odkaz:
https://doaj.org/article/716f99050a144c3382dee490266c2561
Autor:
Wing-Lok Chan MBBS, MSc, Horace Cheuk-Wai Choi PhD, Brian Lang MBBS, MS, Kai-Pun Wong MBBS, MS, Kwok-Keung Yuen MBChB, MSc, Ka-On Lam MBBS, Victor Ho-Fun Lee MBBS, MD, Dora Kwong MBBS, MD
Publikováno v:
Cancer Control, Vol 28 (2021)
Background: Health-related quality of life (HRQoL) is important for differentiated thyroid cancer survivors, but data for Asian survivors is lacking. This study aimed to have an overview of, and identify any disease-or treatment-related factors assoc
Externí odkaz:
https://doaj.org/article/1865c31ff9914a038f85b853d49887d5
Autor:
Kah Poh Loh, Enrique Soto-Perez-de-Celis, Anna Rachelle Mislang, Wing-Lok Chan, Nicolò Matteo Luca Battisti
Publikováno v:
The Lancet. Healthy Longevity, Vol 2, Iss 5, Pp e240-e242 (2021)
Externí odkaz:
https://doaj.org/article/380ba3d1957942198cae186ec2883277
Autor:
Wing-Lok Chan, Tai-Chung Lam, Ka-On Lam, Mai-Yee Luk, Roger Ngan Kai-Cheong, Lai-Wan Dora Kwong
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 12 (2020)
The management of human epidermal growth factor receptor (HER2)-positive breast cancer has improved over the past decade. However, despite improvements in systemic control, a substantial proportion of patients with advanced HER2-positive breast cance
Externí odkaz:
https://doaj.org/article/308a99c09b704705bec513e53dc652f6
Publikováno v:
Life, Vol 12, Iss 1, p 93 (2022)
NCOR2 is a co-repressor for estrogen receptor (ER) and androgen receptor (AR). Our group previously identified a novel splice variant of NCOR2, BQ323636.1 (BQ), that mediates tamoxifen resistance via interference of NCOR2 repression on ER. Luciferase
Externí odkaz:
https://doaj.org/article/60b6e5ba3dc749a3a9b45f9728cfa461
Autor:
Wing-Lok Chan, Yuen-Hung Tricia Ho, Carlos King-Ho Wong, Horace Cheuk-Wai Choi, Ka-On Lam, Kwok-Keung Yuen, Dora Kwong, Ivan Hung
Publikováno v:
Vaccines, Vol 9, Iss 7, p 792 (2021)
Emerging efficacy and safety data have led to the authorization of COVID-19 vaccines worldwide, but most trials excluded patients with active malignancies. This study evaluates the intended acceptance of COVID-19 vaccination in cancer patients in Hon
Externí odkaz:
https://doaj.org/article/08c7820dc0f147c3af2fe73e986c293b
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 11 (2019)
The management of advanced gastric cancer has improved over the past decade. There is more evidence to support the efficacy of systemic treatment in refractory gastric cancer beyond second-line treatment. Important randomized controlled trials of che
Externí odkaz:
https://doaj.org/article/e17bb721ef2a4579813cfbcc70d784fe
Autor:
Wing-Lok Chan, Victor Ho Fun Lee, Wai Kwan Steven Siu, Pui Ying Patty Ho, Rico King Yin Liu, To Wai Leung
Publikováno v:
South Asian Journal of Cancer, Vol 3, Iss 3, Pp 175-178 (2014)
Background: The efficacy and safety of using combination chemotherapy with cetuximab as first-line treatment in patients with K-ras wild-type colorectal cancers has been well established. In general, weekly cetuximab was given with biweekly chemother
Externí odkaz:
https://doaj.org/article/e356b50bd837466ca6bb401c54dda958